Andermann syndrome: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}}<br> | |||
{{Infobox medical condition | |||
| name = Andermann syndrome | |||
| image = [[File:Autosomal_recessive_-_en.svg|200px]] | |||
| caption = Andermann syndrome is inherited in an [[autosomal recessive]] pattern. | |||
| synonyms = Agenesis of the corpus callosum with peripheral neuropathy | |||
| pronounce = | |||
| specialty = [[Neurology]], [[Genetics]] | |||
| symptoms = [[Hypotonia]], [[areflexia]], [[developmental delay]], [[intellectual disability]], [[seizures]], [[dysarthria]], [[scoliosis]], [[peripheral neuropathy]] | |||
| onset = [[Infancy]] | |||
| duration = Lifelong | |||
| causes = Mutations in the [[SLC12A6]] gene | |||
| risks = | |||
| diagnosis = [[Genetic testing]], [[MRI]] | |||
| differential = [[Charcot-Marie-Tooth disease]], [[Friedreich's ataxia]] | |||
| prevention = Genetic counseling | |||
| treatment = Supportive care, [[physical therapy]], [[occupational therapy]], [[speech therapy]] | |||
| medication = | |||
| prognosis = Progressive neurological decline | |||
| frequency = Rare | |||
| deaths = | |||
}} | |||
'''Andermann syndrome''', also known as '''agenesis of corpus callosum with peripheral neuropathy''', is a rare [[genetic disorder]] characterized by the absence or malformation of the [[corpus callosum]] and [[peripheral neuropathy]]. This condition is primarily caused by mutations in the [[SLC12A6]] gene, which is responsible for encoding a protein involved in the transport of ions across cell membranes. | '''Andermann syndrome''', also known as '''agenesis of corpus callosum with peripheral neuropathy''', is a rare [[genetic disorder]] characterized by the absence or malformation of the [[corpus callosum]] and [[peripheral neuropathy]]. This condition is primarily caused by mutations in the [[SLC12A6]] gene, which is responsible for encoding a protein involved in the transport of ions across cell membranes. | ||
== Signs and Symptoms == | == Signs and Symptoms == | ||
Individuals with Andermann syndrome typically present with a range of neurological symptoms, including: | Individuals with Andermann syndrome typically present with a range of neurological symptoms, including: | ||
| Line 8: | Line 29: | ||
* [[Hypotonia]] (reduced muscle tone) | * [[Hypotonia]] (reduced muscle tone) | ||
* [[Peripheral neuropathy]], which may lead to [[muscle weakness]] and [[sensory loss]] | * [[Peripheral neuropathy]], which may lead to [[muscle weakness]] and [[sensory loss]] | ||
== Causes == | == Causes == | ||
Andermann syndrome is caused by mutations in the [[SLC12A6]] gene, which is located on chromosome 15. This gene is responsible for the production of a protein that plays a crucial role in the function of the [[nervous system]]. The disorder is inherited in an [[autosomal recessive]] manner, meaning that an affected individual must inherit two copies of the mutated gene, one from each parent. | Andermann syndrome is caused by mutations in the [[SLC12A6]] gene, which is located on chromosome 15. This gene is responsible for the production of a protein that plays a crucial role in the function of the [[nervous system]]. The disorder is inherited in an [[autosomal recessive]] manner, meaning that an affected individual must inherit two copies of the mutated gene, one from each parent. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of Andermann syndrome is typically based on clinical evaluation, [[genetic testing]], and [[neuroimaging]] studies such as [[MRI]] to assess the structure of the [[brain]]. | Diagnosis of Andermann syndrome is typically based on clinical evaluation, [[genetic testing]], and [[neuroimaging]] studies such as [[MRI]] to assess the structure of the [[brain]]. | ||
== Treatment == | == Treatment == | ||
There is currently no cure for Andermann syndrome, and treatment is primarily supportive. Management strategies may include: | There is currently no cure for Andermann syndrome, and treatment is primarily supportive. Management strategies may include: | ||
| Line 20: | Line 38: | ||
* [[Occupational therapy]] to assist with daily activities | * [[Occupational therapy]] to assist with daily activities | ||
* [[Seizure management]] with [[anticonvulsant medications]] | * [[Seizure management]] with [[anticonvulsant medications]] | ||
== Prognosis == | == Prognosis == | ||
The prognosis for individuals with Andermann syndrome varies depending on the severity of symptoms. Some individuals may have a relatively stable condition, while others may experience progressive neurological decline. | The prognosis for individuals with Andermann syndrome varies depending on the severity of symptoms. Some individuals may have a relatively stable condition, while others may experience progressive neurological decline. | ||
== Epidemiology == | == Epidemiology == | ||
Andermann syndrome is a rare disorder, with a higher prevalence reported in certain populations, such as the [[French-Canadian]] population in the [[ | Andermann syndrome is a rare disorder, with a higher prevalence reported in certain populations, such as the [[French-Canadian]] population in the [[Saguenay–Lac-Saint-Jean]] region of [[Quebec]], [[Canada]]. | ||
== See Also == | == See Also == | ||
* [[Corpus callosum]] | * [[Corpus callosum]] | ||
* [[Peripheral neuropathy]] | * [[Peripheral neuropathy]] | ||
* [[Genetic disorders]] | * [[Genetic disorders]] | ||
== References == | == References == | ||
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1234567/ Example Reference 1] | * [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1234567/ Example Reference 1] | ||
* [https://www.genome.gov/Genetic-Disorders/Andermann-Syndrome Example Reference 2] | * [https://www.genome.gov/Genetic-Disorders/Andermann-Syndrome Example Reference 2] | ||
== External Links == | == External Links == | ||
* [https://rarediseases.info.nih.gov/diseases/1234/andermann-syndrome National Institutes of Health - Andermann Syndrome] | * [https://rarediseases.info.nih.gov/diseases/1234/andermann-syndrome National Institutes of Health - Andermann Syndrome] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Neurological disorders]] | [[Category:Neurological disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
Latest revision as of 14:02, 4 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Andermann syndrome | |
|---|---|
| Synonyms | Agenesis of the corpus callosum with peripheral neuropathy |
| Pronounce | |
| Specialty | Neurology, Genetics |
| Symptoms | Hypotonia, areflexia, developmental delay, intellectual disability, seizures, dysarthria, scoliosis, peripheral neuropathy |
| Complications | N/A |
| Onset | Infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the SLC12A6 gene |
| Risks | |
| Diagnosis | Genetic testing, MRI |
| Differential diagnosis | Charcot-Marie-Tooth disease, Friedreich's ataxia |
| Prevention | Genetic counseling |
| Treatment | Supportive care, physical therapy, occupational therapy, speech therapy |
| Medication | |
| Prognosis | Progressive neurological decline |
| Frequency | Rare |
| Deaths | |
Andermann syndrome, also known as agenesis of corpus callosum with peripheral neuropathy, is a rare genetic disorder characterized by the absence or malformation of the corpus callosum and peripheral neuropathy. This condition is primarily caused by mutations in the SLC12A6 gene, which is responsible for encoding a protein involved in the transport of ions across cell membranes.
Signs and Symptoms[edit]
Individuals with Andermann syndrome typically present with a range of neurological symptoms, including:
- Developmental delay
- Intellectual disability
- Seizures
- Hypotonia (reduced muscle tone)
- Peripheral neuropathy, which may lead to muscle weakness and sensory loss
Causes[edit]
Andermann syndrome is caused by mutations in the SLC12A6 gene, which is located on chromosome 15. This gene is responsible for the production of a protein that plays a crucial role in the function of the nervous system. The disorder is inherited in an autosomal recessive manner, meaning that an affected individual must inherit two copies of the mutated gene, one from each parent.
Diagnosis[edit]
Diagnosis of Andermann syndrome is typically based on clinical evaluation, genetic testing, and neuroimaging studies such as MRI to assess the structure of the brain.
Treatment[edit]
There is currently no cure for Andermann syndrome, and treatment is primarily supportive. Management strategies may include:
- Physical therapy to improve motor skills
- Occupational therapy to assist with daily activities
- Seizure management with anticonvulsant medications
Prognosis[edit]
The prognosis for individuals with Andermann syndrome varies depending on the severity of symptoms. Some individuals may have a relatively stable condition, while others may experience progressive neurological decline.
Epidemiology[edit]
Andermann syndrome is a rare disorder, with a higher prevalence reported in certain populations, such as the French-Canadian population in the Saguenay–Lac-Saint-Jean region of Quebec, Canada.